Dupuytren is complicated. Much of it is a mystery. Because it’s not understood, describing it makes me feel like a character in the parable of the blind men and the elephant.
Seeing the Dupuytren brochure recently released by England’s National Health Service is a pleasant surprise. It summarizes information from publications, answers common questions, and gives a framework for Dupuytren patients to share their issues with doctors and fellow patients. It does not include Xiaflex because this treatment is no longer available in the UK or Europe. Great work, NHS!
Charles Eaton MD